ID   OCI-m/F1
AC   CVCL_LN39
DR   cancercelllines; CVCL_LN39
DR   Wikidata; Q54931780
RX   PubMed=3409229;
CC   Problematic cell line: Contaminated. Grand-parent cell line (Ej138) has been shown to be a T24 derivative.
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; 5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LN38 ! MGH-U1/OCI
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 05-10-23; Version: 11
//
RX   PubMed=3409229;
RA   Kovnat A., Buick R.N., Choo B., de Harven E., Kopelyan I., Trent J.M.,
RA   Tannock I.F.;
RT   "Malignant properties of sublines selected from a human bladder cancer
RT   cell line that contains an activated c-Ha-ras oncogene.";
RL   Cancer Res. 48:4993-5000(1988).
//